H
BMY icon

HoyleCohen’s Bristol-Myers Squibb BMY Stock Holding History

HoyleCohen’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$676K Buy
16,279
+201
+1% +$8.99K 0.05% 163
2024
Q1 		$872K Sell
16,078
-71,387
-82% -$3.64M 0.07% 156
2023
Q4 		$4.49M Sell
87,465
-20,396
-19% -$1.07M 0.37% 73
2023
Q3 		$6.26M Buy
107,861
+997
+0.9% +$61.1K 0.58% 50
2023
Q2 		$6.83M Sell
106,864
-587
-0.5% -$39.4K 0.6% 47
2023
Q1 		$7.45M Sell
107,451
-113
-0.1% -$7.97K 0.69% 43
2022
Q4 		$7.74M Sell
107,564
-723
-0.7% -$54.5K 0.77% 39
2022
Q3 		$7.7M Sell
108,287
-1,532
-1% -$111K 0.84% 31
2022
Q2 		$8.46M Sell
109,819
-1,333
-1% -$102K 0.88% 29
2022
Q1 		$8.12M Sell
111,152
-832
-0.7% -$55.9K 0.7% 36
2021
Q4 		$6.98M Sell
111,984
-2,608
-2% -$153K 0.58% 47
2021
Q3 		$6.78M Buy
114,592
+710
+0.6% +$46.8K 0.64% 43
2021
Q2 		$7.61K Buy
113,882
+221
+0.2% +$14.4K 0.59% 37
2021
Q1 		$7.17M Buy
113,661
+50,521
+80% +$3.14M 0.73% 38
2020
Q4 		$3.92M Sell
63,140
-753
-1% -$46.3K 0.45% 66
2020
Q3 		$3.85M Sell
63,893
-741
-1% -$44.6K 0.57% 52
2020
Q2 		$3.8M Buy
64,634
+1,594
+3% +$95.3K 0.64% 46
2020
Q1 		$3.51M Buy
63,040
+598
+1% +$36.6K 0.7% 40
2019
Q4 		$4.01M Buy
62,442
+36,181
+138% +$2.07M 0.64% 47
2019
Q3 		$1.33M Buy
26,261
+2,740
+12% +$129K 0.23% 91
2019
Q2 		$1.07M Buy
23,521
+4,266
+22% +$199K 0.19% 102
2019
Q1 		$919K Buy
19,255
+2,679
+16% +$133K 0.16% 108
2018
Q4 		$862K Sell
16,576
-1,102
-6% -$59.2K 0.18% 100
2018
Q3 		$1.1M Sell
17,678
-996
-5% -$59.1K 0.21% 89
2018
Q2 		$1.03M Sell
18,674
-1,222
-6% -$66K 0.21% 90
2018
Q1 		$1.26M Buy
19,896
+503
+3% +$32.4K 0.26% 81
2017
Q4 		$1.19M Buy
+19,393
New +$1.21M 0.23% 86

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HoyleCohen's BMY Position: Q2 2024 in Review

HoyleCohen increased its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2024, buying an estimated $8.99K and bringing the position to 16,279 shares worth $676K. The position accounts for 0.05% of the portfolio, ranked #163.

HoyleCohen first reported a position in BMY in Q4 2017 and has held it in 27 quarters since. The position peaked at $8.46M in Q2 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • HoyleCohen held 16,279 shares of Bristol-Myers Squibb worth $676K as of Q2 2024.
  • HoyleCohen bought 201 Bristol-Myers Squibb shares in Q2 2024, an estimated $8.99K.
  • Bristol-Myers Squibb made up 0.05% of HoyleCohen's portfolio in Q2 2024, its #163 holding.
  • HoyleCohen first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 27 quarters since.
  • HoyleCohen's Bristol-Myers Squibb position peaked at $8.46M in Q2 2022.
  • 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.